Continue reading by scrolling after the advertisement.
'Ultraman Cosmos' lead actor Taiyo Sugiura tests positive for COVID-19
September 15, 2020 at 6:49 PM PHT (GMT +8)
Japanese news agency Oricon News reported that the official blog of Japanese actor Taiyo Sugiura published an announcement from the staff stating that the Ultraman Cosmos lead actor has tested positive for the novel coronavirus disease (COVID-19). The actor in his 39, was immediately hospitalized after his family received the result of the PCR test on Tuesday, Sept. 15.
Press/click the image to enlarge.
Photo Grabbed from Ultraman Cosmos TV series
His wife, Nozomi Tsuji - a Japanese media personality, singer, and blogger, also reported an update regarding the current situation of his family through her blog. She stated that her family decided to undergo PCR testing after her husband experiences fever for days and just this day, the results came confirming that his husband tested positive for the virus and was immediately admitted to the hospital. She also added that she and her children tested negative and have no symptoms of the disease.
In addition, she told her readers that they will follow strict health guidelines and expressed her apology to those who made them concern and gratitude to the medical staff who are attending their needs.
According to Sugiura's staff as of writing, the actor's temperature return to normal but still has cough, and they are looking for a full recovery soon.
Taiyo Sugiura made his debut in 1998 with TV Asahi, where he appeared in several dramas. In 2001, he was cast in and starred for Ultraman Cosmos. This was followed by his appearance in the 2003 Ultraman Cosmos vs. Ultraman Justice: The Final Battle.
On June 17, 2007, Sugiura married Nozomi Tsuji while she was three months pregnant; the marriage was confirmed to be a shotgun wedding. Sugiura and Tsuji met in April 2006 through mutual friends. The couple have four children: a daughter named Noa, and three sons named Seia, Sora and Koa who were born 2007, 2010, 2013 and 2018, respectively.